临床荟萃

• 专题 • 上一篇    下一篇

2016年风湿免疫病主要临床研究进展

  

  1. 河北医科大学第二医院 风湿免疫科,河北 石家庄 050000
  • 出版日期:2017-02-05 发布日期:2017-02-08
  • 通讯作者: 通信作者:郭惠芳,Email:guohfch@126.com
  • 作者简介:郭惠芳:女,1990年毕业于河北医科大学医学系。现任河北医科大学第二医院风湿免疫科副主任,医学博士,主任医师,教授,硕士生导师。任河北省医学会风湿病分会常务委员,河北省免疫学会理事,河北省免疫学会风湿病专业委员会常务委员,河北省医师学会风湿病分会常务委员,一直从事风湿免疫病的临床、教学和科研工作。擅长系统性红斑狼疮、类风湿关节炎、炎症性肌病、系统性血管炎以及强直性脊柱炎、痛风等风湿免疫病的诊治。主研省厅级课题7项,在国内外专业杂志上发表论文40余篇。获得省科技进步三等奖2项。

Major advances in clinical research of rheumatic diseases of 2016

  1. Department of Rheumatology and Immunology, the Second Hospital of Hebei Medical University,
    Shijiazhuang 050000,China
  • Online:2017-02-05 Published:2017-02-08
  • Contact: Corresponding author:Guo Huifang,Email:guohfch@126.com

摘要: 2016年,类风湿关节炎、干燥综合征、痛风等多种风湿病的诊治指南再次更新,“长程管理、达标治疗”的理念已经从类风湿关节炎,逐渐渗透到系统性红斑狼疮、痛风、脊柱关节炎等多种疾病的治疗决策中。新型生物制剂不断涌现,传统抗风湿药物和生物制剂的应用和转换原则越来越清晰明确,风湿免疫病的诊断和治疗方法越来越规范。

关键词: 关节炎, 类风湿, 红斑狼疮, 干燥综合征, 痛风, 风湿病, 诊断, 治疗进展

Abstract: In 2016, many guidelines for the diagnosis and treatment of rheumatoid arthritis, Sjgren  syndrome, gout and other rheumatic diseases updated again.The concepts  of  “long range management, treat to target”   which originated from the management of rheumatoid arthritis, have gradually infiltrated into the treatment decisions about systemic lupus erythematosus,gout,spondyloarthritis and other rheumatic diseases. New biological agents continue to emerge.The exchange principles  from traditional disease modifying antirheumatic drugs to biological agents have been more and more organized. The diagnosis and treatment methods of rheumatic disease have been more and more standardized.

Key words: arthritis, rheumatoid, lupus erythematosus;Sjgren , syndrome;gout, rheumatic disease, diagnosis, treatment progress